Global Biopharmaceutical and Vaccine Production Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Table of Contents
1 Biopharmaceutical and Vaccine Production Market Overview
- 1.1 Product Overview and Scope of Biopharmaceutical and Vaccine Production
- 1.2 Classification of Biopharmaceutical and Vaccine Production by Types
- 1.2.1 Global Biopharmaceutical and Vaccine Production Revenue Comparison by Types (2019-2024)
- 1.2.2 Global Biopharmaceutical and Vaccine Production Revenue Market Share by Types in 2018
- 1.2.3 Biopharmaceutical
- 1.2.4 Vaccine Production
- 1.3 Global Biopharmaceutical and Vaccine Production Market by Application
- 1.3.1 Global Biopharmaceutical and Vaccine Production Market Size and Market Share Comparison by Applications (2014-2024)
- 1.3.2 Pharmaceutical
- 1.3.3 Biotechnology
- 1.3.4 Academic and Research Institutes
- 1.3.5 Others
- 1.4 Global Biopharmaceutical and Vaccine Production Market by Regions
- 1.4.1 Global Biopharmaceutical and Vaccine Production Market Size (Million USD) Comparison by Regions (2014-2024)
- 1.4.1 North America (USA, Canada and Mexico) Biopharmaceutical and Vaccine Production Status and Prospect (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy) Biopharmaceutical and Vaccine Production Status and Prospect (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biopharmaceutical and Vaccine Production Status and Prospect (2014-2024)
- 1.4.4 South America (Brazil, Argentina, Colombia) Biopharmaceutical and Vaccine Production Status and Prospect (2014-2024)
- 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biopharmaceutical and Vaccine Production Status and Prospect (2014-2024)
- 1.5 Global Market Size of Biopharmaceutical and Vaccine Production (2014-2024)
2 Manufacturers Profiles
- 2.1 Novartis
- 2.1.1 Business Overview
- 2.1.2 Biopharmaceutical and Vaccine Production Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Novartis Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Pfizer
- 2.2.1 Business Overview
- 2.2.2 Biopharmaceutical and Vaccine Production Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Pfizer Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Sanofi
- 2.3.1 Business Overview
- 2.3.2 Biopharmaceutical and Vaccine Production Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Sanofi Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 Roche
- 2.4.1 Business Overview
- 2.4.2 Biopharmaceutical and Vaccine Production Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 Roche Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 Abbott
- 2.5.1 Business Overview
- 2.5.2 Biopharmaceutical and Vaccine Production Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Abbott Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
- 2.6 Regeneron Pharmaceuticals
- 2.6.1 Business Overview
- 2.6.2 Biopharmaceutical and Vaccine Production Type and Applications
- 2.6.2.1 Product A
- 2.6.2.2 Product B
- 2.6.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
- 2.7 Alexion Pharmaceuticals
- 2.7.1 Business Overview
- 2.7.2 Biopharmaceutical and Vaccine Production Type and Applications
- 2.7.2.1 Product A
- 2.7.2.2 Product B
- 2.7.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
- 2.8 Johnson and Johnson
- 2.8.1 Business Overview
- 2.8.2 Biopharmaceutical and Vaccine Production Type and Applications
- 2.8.2.1 Product A
- 2.8.2.2 Product B
- 2.8.3 Johnson and Johnson Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
- 2.9 GlaxoSmithKline
- 2.9.1 Business Overview
- 2.9.2 Biopharmaceutical and Vaccine Production Type and Applications
- 2.9.2.1 Product A
- 2.9.2.2 Product B
- 2.9.3 GlaxoSmithKline Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
- 2.10 Merck
- 2.10.1 Business Overview
- 2.10.2 Biopharmaceutical and Vaccine Production Type and Applications
- 2.10.2.1 Product A
- 2.10.2.2 Product B
- 2.10.3 Merck Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
- 2.11 Lonza
- 2.11.1 Business Overview
- 2.11.2 Biopharmaceutical and Vaccine Production Type and Applications
- 2.11.2.1 Product A
- 2.11.2.2 Product B
- 2.11.3 Lonza Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
- 2.12 FUJIFILM Diosynth Biotechnologies
- 2.12.1 Business Overview
- 2.12.2 Biopharmaceutical and Vaccine Production Type and Applications
- 2.12.2.1 Product A
- 2.12.2.2 Product B
- 2.12.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
3 Global Biopharmaceutical and Vaccine Production Market Competition, by Players
- 3.1 Global Biopharmaceutical and Vaccine Production Revenue and Share by Players (2014-2019)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Biopharmaceutical and Vaccine Production Players Market Share
- 3.2.2 Top 10 Biopharmaceutical and Vaccine Production Players Market Share
- 3.3 Market Competition Trend
4 Global Biopharmaceutical and Vaccine Production Market Size by Regions
- 4.1 Global Biopharmaceutical and Vaccine Production Revenue and Market Share by Regions
- 4.2 North America Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 4.3 Europe Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 4.5 South America Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
5 North America Biopharmaceutical and Vaccine Production Revenue by Countries
- 5.1 North America Biopharmaceutical and Vaccine Production Revenue by Countries (2014-2019)
- 5.2 USA Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 5.3 Canada Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 5.4 Mexico Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
6 Europe Biopharmaceutical and Vaccine Production Revenue by Countries
- 6.1 Europe Biopharmaceutical and Vaccine Production Revenue by Countries (2014-2019)
- 6.2 Germany Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 6.3 UK Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 6.4 France Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 6.5 Russia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 6.6 Italy Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Biopharmaceutical and Vaccine Production Revenue by Countries
- 7.1 Asia-Pacific Biopharmaceutical and Vaccine Production Revenue by Countries (2014-2019)
- 7.2 China Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 7.3 Japan Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 7.4 Korea Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 7.5 India Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 7.6 Southeast Asia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
8 South America Biopharmaceutical and Vaccine Production Revenue by Countries
- 8.1 South America Biopharmaceutical and Vaccine Production Revenue by Countries (2014-2019)
- 8.2 Brazil Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 8.3 Argentina Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 8.4 Colombia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Biopharmaceutical and Vaccine Production by Countries
- 9.1 Middle East and Africa Biopharmaceutical and Vaccine Production Revenue by Countries (2014-2019)
- 9.2 Saudi Arabia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 9.3 UAE Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 9.4 Egypt Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 9.5 Nigeria Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
- 9.6 South Africa Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
10 Global Biopharmaceutical and Vaccine Production Market Segment by Type
- 10.1 Global Biopharmaceutical and Vaccine Production Revenue and Market Share by Type (2014-2019)
- 10.2 Global Biopharmaceutical and Vaccine Production Market Forecast by Type (2019-2024)
- 10.3 Biopharmaceutical Revenue Growth Rate (2014-2024)
- 10.4 Vaccine Production Revenue Growth Rate (2014-2024)
11 Global Biopharmaceutical and Vaccine Production Market Segment by Application
- 11.1 Global Biopharmaceutical and Vaccine Production Revenue Market Share by Application (2014-2019)
- 11.2 Biopharmaceutical and Vaccine Production Market Forecast by Application (2019-2024)
- 11.3 Pharmaceutical Revenue Growth (2014-2019)
- 11.4 Biotechnology Revenue Growth (2014-2019)
- 11.5 Academic and Research Institutes Revenue Growth (2014-2019)
- 11.6 Others Revenue Growth (2014-2019)
12 Global Biopharmaceutical and Vaccine Production Market Size Forecast (2019-2024)
- 12.1 Global Biopharmaceutical and Vaccine Production Market Size Forecast (2019-2024)
- 12.2 Global Biopharmaceutical and Vaccine Production Market Forecast by Regions (2019-2024)
- 12.3 North America Biopharmaceutical and Vaccine Production Revenue Market Forecast (2019-2024)
- 12.4 Europe Biopharmaceutical and Vaccine Production Revenue Market Forecast (2019-2024)
- 12.5 Asia-Pacific Biopharmaceutical and Vaccine Production Revenue Market Forecast (2019-2024)
- 12.6 South America Biopharmaceutical and Vaccine Production Revenue Market Forecast (2019-2024)
- 12.7 Middle East and Africa Biopharmaceutical and Vaccine Production Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
Biopharmaceutical is a pharmaceutical derived from biological sources and especially one produced by biotechnology. A vaccine is a biological preparation that provides active acquired immunity to a particular disease.
Scope of the Report:
The global Biopharmaceutical and Vaccine Production market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biopharmaceutical and Vaccine Production.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Biopharmaceutical and Vaccine Production market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biopharmaceutical and Vaccine Production market by product type and applications/end industries.
Market Segment by Companies, this report covers
Novartis
Pfizer
Sanofi
Roche
Abbott
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline
Merck
Lonza
FUJIFILM Diosynth Biotechnologies
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Biopharmaceutical
Vaccine Production
Market Segment by Applications, can be divided into
Pharmaceutical
Biotechnology
Academic and Research Institutes
Others